Lyell Immunopharma Growth Metrics (2020-2026) | LYEL

Growth Metrics Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter)
0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M-59.42M
EBITDA Margin Growth (3y) (Quarter)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M-93.93M
EBITDA Margin Growth (5y) (Quarter)
-58.60M-24.49M-212.57M-221.08M-118.10M
EBITDA Margin (QoQ) (Quarter)
0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.56M102.96M
EBIT Margin Growth (1y) (Quarter)
0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M-59.42M
EBIT Margin Growth (3y) (Quarter)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M-93.93M
EBIT Margin Growth (5y) (Quarter)
-58.60M-24.49M-212.57M-221.08M-118.10M
EBIT Margin (QoQ) (Quarter)
0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.56M102.96M
EBT Margin Growth (1y) (Quarter)
0.13M-0.42M-2.94M0.63M-627.71M0.62M-9.65M-33.60M599.91M-236.03M-236.88M-65.97M-8.57M-274.02M65.58M-44.73M-31.52M268.90M-331.96M-113.02M
EBT Margin Growth (3y) (Quarter)
-33.30M-27.67M-235.83M-249.47M-98.94M-36.37M-509.43M-180.95M-144.30M559.81M-241.15M-503.26M-200.48M
EBT Margin Growth (5y) (Quarter)
-144.01M-67.76M-240.95M-515.85M-256.69M
EBT Margin (QoQ) (Quarter)
0.44M-0.40M-2.55M3.13M-627.89M627.92M-12.81M-20.82M5.61M-208.01M-13.67M150.10M63.01M-473.46M325.93M39.78M76.22M-173.04M-274.93M258.73M
Enterprise Value Growth (1y) (Quarter)
-358.87%-0.36%-151.22%20.49%-4.72%-4.12%0.19%9.12%11.22%14.67%14.11%17.56%23.44%32.17%42.77%43.64%27.45%33.28%15.66%26.26%
Enterprise Value Growth (3y) (Quarter)
-34.21%-62.19%3.75%-29.14%15.86%10.71%15.53%21.13%24.98%20.99%27.18%25.44%30.03%
Enterprise Value Growth (5y) (Quarter)
-2.35%-18.83%16.60%-0.78%24.36%
Enterprise Value (QoQ) (Quarter)
24.94%0.67%0.14%-6.78%1.13%1.23%4.28%2.78%3.41%5.08%3.65%6.68%10.30%15.89%18.72%8.10%-15.48%22.65%-2.75%19.65%
FCF Margin Growth (1y) (Quarter)
0.23M-0.07M-0.67M0.09M-177.39M0.33M-6.48M-14.84M163.39M-33.32M-132.81M-14.47M3.67M-9.37M61.73M-14.08M-8.36M-12.36M-114.58M-41.91M
FCF Margin Growth (3y) (Quarter)
-13.77M-33.06M-139.96M-29.22M-10.33M-42.37M-77.55M-43.38M158.70M-55.05M-185.65M-70.34M
FCF Margin Growth (5y) (Quarter)
-18.46M-54.79M-192.80M-84.97M
FCF Margin (QoQ) (Quarter)
0.01M-0.24M-0.54M0.85M-177.47M177.48M-7.34M-7.50M0.76M-19.23M-106.83M110.83M18.90M-32.28M-35.72M35.02M24.62M-36.28M-137.94M108.32M
Interest Coverage Ratio Growth (1y) (Quarter)
98.63%27.42%87.25%-3,278.86%-279.51%-509.42%-775.59%98.10%-14.29%73.52%86.09%-133.61%72.49%-4.53%14.90%-1,234.66%6.18%-23.55%
Interest Coverage Ratio Growth (3y) (Quarter)
79.34%-5.41%46.25%-14.41%-6.06%-19.04%-1.21%16.05%33.43%-4.91%
Interest Coverage Ratio Growth (5y) (Quarter)
22.77%-8.63%
Interest Coverage Ratio (QoQ) (Quarter)
-667.65%91.38%-80.26%39.18%-34.83%-2,186.00%79.75%2.34%-93.71%95.05%-1,119.52%77.37%-1.80%16.83%-43.61%14.02%17.13%-1,204.38%89.91%-13.22%
Net Margin Growth (1y) (Quarter)
0.13M-0.42M-2.94M0.63M-627.71M0.62M-9.65M-33.60M599.91M-236.03M-236.88M-65.97M-8.57M-274.02M65.58M-44.73M-31.52M268.90M-331.96M-113.02M
Net Margin Growth (3y) (Quarter)
-33.30M-27.67M-235.83M-249.47M-98.94M-36.37M-509.43M-180.95M-144.30M559.81M-241.15M-503.26M-200.48M
Net Margin Growth (5y) (Quarter)
-144.01M-67.76M-240.95M-515.85M-256.69M
Net Margin (QoQ) (Quarter)
0.44M-0.40M-2.55M3.13M-627.89M627.92M-12.81M-20.82M5.61M-208.01M-13.67M150.10M63.01M-473.46M325.93M39.78M76.22M-173.04M-274.93M258.73M
Operating Margin Growth (1y) (Quarter)
0.17M0.00M-1.01M0.23M-221.28M0.17M-8.38M-24.40M197.84M-45.77M-175.63M-15.23M8.76M-137.09M103.30M-19.29M-9.98M-29.88M-139.35M-59.42M
Operating Margin Growth (3y) (Quarter)
-24.08M-23.27M-45.60M-185.02M-39.40M-14.68M-182.69M-80.71M-58.91M196.62M-212.74M-211.68M-93.93M
Operating Margin Growth (5y) (Quarter)
-58.60M-24.49M-212.57M-221.08M-118.10M
Operating Margin (QoQ) (Quarter)
0.06M0.01M-1.07M1.23M-221.45M221.45M-9.62M-14.79M0.79M-22.16M-139.47M145.61M24.78M-168.01M100.91M23.03M34.09M-187.90M-8.56M102.96M
Return on Assets Growth (1y) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.00-1.00-1.00-1.00-1.000.00M1.001.00
Return on Assets Growth (3y) (Quarter)
-1.00-1.00-2.00-2.00-2.00-1.00-1.00-1.00
Return on Assets (QoQ) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M-1.000.00M0.00M0.00M1.000.00M0.00M
Return on Capital Employed Growth (1y) (Quarter)
-528.00-108.0092.00-514.00-275.00-0.00M-0.00M-961.00-0.00M-0.00M-0.01M-0.01M-0.01M-0.00M293.00794.00
Return on Capital Employed Growth (3y) (Quarter)
-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Return on Capital Employed (QoQ) (Quarter)
-134.00-229.00121.00-286.00286.00-29.00-485.00-47.00-754.00-133.00-28.00-92.00-0.00M-0.00M-0.00M208.000.00M-11.00-503.00
Return on Sales Growth (1y) (Quarter)
13.00-42.00-294.0063.00-0.06M62.00-965.00-0.00M0.06M-0.02M-0.02M-0.01M-857.00-0.03M0.01M-0.00M-0.00M0.03M-0.03M-0.01M
Return on Sales Growth (3y) (Quarter)
-0.00M-0.00M-0.02M-0.02M-0.01M-0.00M-0.05M-0.02M-0.01M0.06M-0.02M-0.05M-0.02M
Return on Sales Growth (5y) (Quarter)
-0.01M-0.01M-0.02M-0.05M-0.03M
Return on Sales (QoQ) (Quarter)
44.00-40.00-255.00313.00-0.06M0.06M-0.00M-0.00M561.00-0.02M-0.00M0.02M0.01M-0.05M0.03M0.00M0.01M-0.02M-0.03M0.03M